Improving MRI patient compliance

Article

According to an article in the January 2010 issue of Radiology women with elevated risk of breast cancer are likely to refuse an MRI -- even when it won't cost them anything.

According to an article in the January 2010 issue of Radiology women with elevated risk of breast cancer are likely to refuse an MRI -- even when it won't cost them anything.

Researchers offered 1215 women the screening, but 42% refused the test. The top concern women cited was claustrophobia. Just over 5% were worried about injection of contrast materials.

What techniques do you use to improve patient compliance with recommended screenings?

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe Now!
Recent Videos
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Related Content
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma

Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma

Jeff Hall
July 14th 2025
Article

For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates

New FDA-Approved Dosing Schedule for Donanemab May Reduce ARIA-E Rates

Jeff Hall
July 9th 2025
Article

Findings from the TRAILBLAZER-ALZ 6 study revealed a 41 percent reduction of the ARIA-E side effect at 24 weeks with the new dosing schedule for the anti-amyloid treatment donanemab-azbt.

The Reading Room: Potential fMRI Alternative -- fPACT

The Reading Room: Potential fMRI Alternative -- fPACT

Whitney J. Palmer
June 23rd 2021
Podcast

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

FDA Clears SmartSpeed Precise MRI Software from Philips

FDA Clears SmartSpeed Precise MRI Software from Philips

Jeff Hall
July 2nd 2025
Article

The deep learning reconstruction software reportedly facilitates accelerated MRI scanning and significantly enhanced image sharpness.

Cardiac MRI Study Affirms Link Between Air Pollution Exposure and Increased Diffuse Myocardial Fibrosis

Cardiac MRI Study Affirms Link Between Air Pollution Exposure and Increased Diffuse Myocardial Fibrosis

Jeff Hall
July 1st 2025
Article

For people with dilated cardiomyopathy and those with initially normal cardiac MRI, each 1 ug/m3 increase in one-year exposure to ambient fine particulate matter with 2.5-um > aerodynamic diameter was associated with significantly more diffuse myocardial fibrosis, according to a recent study.

© 2025 MJH Life Sciences

All rights reserved.